Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021

Tietueen suppeat tiedot
dc.contributor.authorKant Ravi
dc.contributor.authorNguyen Phuoc Truong
dc.contributor.authorBlomqvist Soile
dc.contributor.authorErdin Mert
dc.contributor.authorAlburkat Hussein
dc.contributor.authorSuvanto Maija
dc.contributor.authorZakham Fathiah
dc.contributor.authorSalminen Veera
dc.contributor.authorOlander Viktor
dc.contributor.authorPaloniemi Minna
dc.contributor.authorHuhti Leena
dc.contributor.authorLehtinen Sara
dc.contributor.authorLuukinen Bruno
dc.contributor.authorJarva Hanna
dc.contributor.authorKallio-Kokko Hannimari
dc.contributor.authorKurkela Satu
dc.contributor.authorLappalainen Maija
dc.contributor.authorLiimatainen Hanna
dc.contributor.authorHannula Sari
dc.contributor.authorHalkilahti Jani
dc.contributor.authorIkonen Jonna
dc.contributor.authorIkonen Niina
dc.contributor.authorHelve Otto
dc.contributor.authorGunell Marianne
dc.contributor.authorVuorinen Tytti
dc.contributor.authorPlyusnin Ilya
dc.contributor.authorLindh Erika
dc.contributor.authorEllonen Pekka
dc.contributor.authorSironen Tarja
dc.contributor.authorSavolainen-Kopra Carita
dc.contributor.authorSmura Teemu
dc.contributor.authorVapalahti Olli
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id68439444
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/68439444
dc.date.accessioned2022-10-28T13:17:55Z
dc.date.available2022-10-28T13:17:55Z
dc.description.abstractSevere acute respiratory syndrome coronavirus 2 Alpha and Beta variants became dominant in Finland in spring 2021 but had diminished by summer. We used phylogenetic clustering to identify sources of spreading. We found that outbreaks were mostly seeded by a few introductions, highlighting the importance of surveillance and prevention policies.
dc.format.pagerange3137
dc.format.pagerange3141
dc.identifier.jour-issn1080-6040
dc.identifier.olddbid181129
dc.identifier.oldhandle10024/164223
dc.identifier.urihttps://www.utupub.fi/handle/11111/37141
dc.identifier.urlhttps://wwwnc.cdc.gov/eid/article/27/12/21-1631_article
dc.identifier.urnURN:NBN:fi-fe2022012710881
dc.language.isoen
dc.okm.affiliatedauthorGunell, Marianne
dc.okm.affiliatedauthorVuorinen, Tytti
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherCENTERS DISEASE CONTROL & PREVENTION
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.3201/eid2712.211631
dc.relation.ispartofjournalEmerging Infectious Diseases
dc.relation.issue12
dc.relation.volume27
dc.source.identifierhttps://www.utupub.fi/handle/10024/164223
dc.titleIncidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Name:
21-1631-combined.pdf
Size:
1.77 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF
Lataa

Kokoelmat

Rinnakkaistallenteet